These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 31470292)
1. Simultaneous inhibition of neprilysin and activation of ACE2 prevented diabetic cardiomyopathy. Malek V; Sharma N; Gaikwad AB Pharmacol Rep; 2019 Oct; 71(5):958-967. PubMed ID: 31470292 [TBL] [Abstract][Full Text] [Related]
2. Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy. Malek V; Sharma N; Sankrityayan H; Gaikwad AB Life Sci; 2019 Mar; 221():159-167. PubMed ID: 30769114 [TBL] [Abstract][Full Text] [Related]
3. Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy. Malek V; Gaikwad AB Cardiovasc Res; 2019 Feb; 115(2):373-384. PubMed ID: 30184174 [TBL] [Abstract][Full Text] [Related]
4. Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT Goru SK; Kadakol A; Malek V; Pandey A; Sharma N; Gaikwad AB Br J Pharmacol; 2017 Sep; 174(18):3118-3130. PubMed ID: 28688122 [TBL] [Abstract][Full Text] [Related]
5. Histone Acetylation Regulates Natriuretic Peptides and Neprilysin Gene Expressions in Diabetic Cardiomyopathy and Nephropathy. Malek V; Sharma N; Gaikwad AB Curr Mol Pharmacol; 2019; 12(1):61-71. PubMed ID: 30465518 [TBL] [Abstract][Full Text] [Related]
6. Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats. Coutinho DC; Monnerat-Cahli G; Ferreira AJ; Medei E Europace; 2014 Nov; 16(11):1689-96. PubMed ID: 24741027 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice. Qiu Y; Shil PK; Zhu P; Yang H; Verma A; Lei B; Li Q Invest Ophthalmol Vis Sci; 2014 May; 55(6):3809-18. PubMed ID: 24854854 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of endoplasmic reticulum stress combined with activation of angiotensin-converting enzyme 2: novel approach for the prevention of endothelial dysfunction in type 1 diabetic rats. Sankrityayan H; Kale A; Gaikwad AB Can J Physiol Pharmacol; 2022 Mar; 100(3):234-239. PubMed ID: 34587465 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 2 receptor and angiotensin-converting enzyme 2 mediate ischemic renal injury in diabetic and non-diabetic rats. Sharma N; Malek V; Mulay SR; Gaikwad AB Life Sci; 2019 Oct; 235():116796. PubMed ID: 31470003 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic Activation of Angiotensin-Converting Enzyme II Alleviates Diabetic Cardiomyopathy in db/db Mice by Reducing Reactive Oxidative Stress. Kim D; Jeong W; Kim Y; Lee J; Cho SW; Oh CM; Park R Diabetes Metab J; 2023 Jul; 47(4):487-499. PubMed ID: 37096378 [TBL] [Abstract][Full Text] [Related]
11. Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model. Dhawale VS; Amara VR; Karpe PA; Malek V; Patel D; Tikoo K Toxicol Appl Pharmacol; 2016 Sep; 306():17-26. PubMed ID: 27343405 [TBL] [Abstract][Full Text] [Related]
12. Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats? Badae NM; El Naggar AS; El Sayed SM Can J Physiol Pharmacol; 2019 Jul; 97(7):638-646. PubMed ID: 30840489 [TBL] [Abstract][Full Text] [Related]
13. Effects of renal ischemia injury on brain in diabetic and non-diabetic rats: Role of angiotensin II type 2 receptor and angiotensin-converting enzyme 2. Sharma N; Gaikwad AB Eur J Pharmacol; 2020 Sep; 882():173241. PubMed ID: 32565336 [TBL] [Abstract][Full Text] [Related]
15. Isosteviol ameliorates diabetic cardiomyopathy in rats by inhibiting ERK and NF-κB signaling pathways. Tang SG; Liu XY; Ye JM; Hu TT; Yang YY; Han T; Tan W J Endocrinol; 2018 Jul; 238(1):47-60. PubMed ID: 29720537 [TBL] [Abstract][Full Text] [Related]
16. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway. Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708 [TBL] [Abstract][Full Text] [Related]
17. Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2. Hu X; Rajesh M; Zhang J; Zhou S; Wang S; Sun J; Tan Y; Zheng Y; Cai L Toxicol Lett; 2018 May; 287():131-141. PubMed ID: 29408448 [TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer-binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin-converting enzyme-2 expression in diabetes. Tie Y; Zhai C; Zhang Y; Qin X; Yu F; Li H; Shan M; Zhang C J Cell Mol Med; 2018 Mar; 22(3):1475-1488. PubMed ID: 29266779 [TBL] [Abstract][Full Text] [Related]
19. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway. Liu X; Guo B; Zhang W; Ma B; Li Y J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411 [TBL] [Abstract][Full Text] [Related]
20. Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension. Kangussu LM; de Almeida TCS; Prestes TRR; de Andrade De Maria ML; da Silva Filha R; Vieira MAR; Silva ACSE; Ferreira AJ Protein Pept Lett; 2019; 26(7):523-531. PubMed ID: 30950337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]